One cannot rule them all: Are bacterial toxins-antitoxins druggable?

FEMS Microbiology Reviews
Wai Ting ChanManuel Espinosa

Abstract

Type II (proteic) toxin-antitoxin (TA) operons are widely spread in bacteria and archaea. They are organized as operons in which, usually, the antitoxin gene precedes the cognate toxin gene. The antitoxin generally acts as a transcriptional self-repressor, whereas the toxin acts as a co-repressor, both proteins constituting a harmless complex. When bacteria encounter a stressful environment, TAs are triggered. The antitoxin protein is unstable and will be degraded by host proteases, releasing the free toxin to halt essential processes. The result is a cessation of cell growth or even death. Because of their ubiquity and the essential processes targeted, TAs have been proposed as good candidates for development of novel antimicrobials. We discuss here the possible druggability of TAs as antivirals and antibacterials, with focus on the potentials and the challenges that their use may find in the 'real' world. We present strategies to develop TAs as antibacterials in view of novel technologies, such as the use of very small molecules (fragments) as inhibitors of protein-protein interactions. Appropriate fragments could disrupt the T:A interfaces leading to the release of the targeted TA pair. Possible ways of delivery and formulat...Continue Reading

References

Dec 1, 1994·Bio/technology·J L RamosK N Timmis
May 1, 1997·Applied and Environmental Microbiology·D C PecotaT K Wood
Oct 10, 1998·Clinical Microbiology Reviews·S L Kaplan, E O Mason
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y XuC H Johnson
Jan 23, 1999·The Journal of Biological Chemistry·E Gazit, R T Sauer
Jan 26, 1999·Journal of Molecular Biology·R LorisL Wyns
Nov 5, 1999·Annual Review of Microbiology·H Engelberg-Kulka, G Glaser
Jan 19, 2000·Gene Therapy·P F ChinneryR N Lightowlers
Jun 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Ray, B Nordén
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·S K ChristensenK Gerdes
Mar 14, 2002·International Journal of Medical Microbiology : IJMM·Laurence Van Melderen
Oct 16, 2002·Structure·David HargreavesJohn B Rafferty
Jan 7, 2003·The EMBO Journal·Guillermo de la Cueva-MéndezRonald A Laskey
Apr 30, 2003·Molecular Cell·Katsuhiko KamadaStephen K Burley
Oct 14, 2003·Drug Discovery Today·Miles CongreveHarren Jhoti
Dec 10, 2003·Microbiology·Begoña TorresEduardo Díaz
Jan 17, 2004·Applied Microbiology and Biotechnology·D RenT K Wood
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Jun 25, 2004·Journal of Medicinal Chemistry·Daniel A ErlansonTom O'Brien
Oct 16, 2004·Expert Review of Anti-infective Therapy·Andrea Marra
Nov 9, 2004·The Journal of Antimicrobial Chemotherapy·Erwin M Brown, Dilip Nathwani
Feb 19, 2005·Nucleic Acids Research·Deo Prakash Pandey, Kenn Gerdes
Feb 22, 2005·Advanced Drug Delivery Reviews·Matjaz Zorko, Ulo Langel
Apr 20, 2005·Molecular Cell·Motoo SuzukiMasayori Inouye
Apr 28, 2005·Journal of Molecular Biology·Minh-Hoa Dao-ThiRemy Loris
Apr 28, 2005·Lab on a Chip·Jose Rojas-ChapanaMichael Giersig
May 3, 2005·Nature Reviews. Microbiology·Kenn GerdesAnders Løbner-Olesen
Jul 12, 2005·Antiviral Chemistry & Chemotherapy·Eddy Littler, Bo Oberg
Aug 20, 2005·Journal of Bacteriology·Urszula Zielenkiewicz, Piotr Ceglowski

❮ Previous
Next ❯

Citations

Aug 13, 2015·Biotechnology and Bioengineering·Thomas K Wood
Apr 6, 2016·Frontiers in Molecular Biosciences·Wai Ting ChanChew Chieng Yeo
Feb 15, 2015·Plasmid·M Pilar Garcillán-Barcia, Manuel Espinosa
May 11, 2016·Toxins·Christopher F Schuster, Ralph Bertram
Jul 28, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Xiaoxue Wang, Thomas K Wood
Jun 21, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Barbara Kędzierska, Finbarr Hayes
Jul 21, 2016·Chemical Reviews·Laura Nunes SilvaDanielle Silva Trentin
Aug 4, 2018·Wiley Interdisciplinary Reviews. RNA·Radoslaw Pluta, Manuel Espinosa
May 9, 2019·Toxins·Olga Soutourina
Sep 20, 2019·Nature Reviews. Microbiology·Roy Z Moger-Reischer, Jay T Lennon
Jul 26, 2017·Proceedings of the National Academy of Sciences of the United States of America·Radoslaw PlutaMiquel Coll
Aug 9, 2017·Expert Review of Proteomics·Alla GagarinovaMohan Babu
Nov 28, 2019·International Journal of Molecular Sciences·Rawana N AlkhaliliBjörn Canbäck
Oct 19, 2019·Médecine sciences : M/S·Claude Gutierrez, Olivier Neyrolles
Feb 28, 2019·Biomolecular Concepts·Alicia BravoManuel Espinosa
Jun 10, 2020·Chembiochem : a European Journal of Chemical Biology·Shahrzad Jahanshahi, Yingfu Li
Apr 28, 2017·FEMS Microbiology Reviews·Qiu E Yang, Timothy R Walsh
May 25, 2016·Experimental Biology and Medicine·Nathan P Coussens, Dayle A Daines
Jul 12, 2017·Microbiology·Bhaskar Chandra Mohan Ramisetty, Ramachandran Sarojini Santhosh
Feb 17, 2019·Nature Communications·Valérie GuilletLionel Mourey
Sep 10, 2020·Toxins·Marcin RównickiDariusz Bartosik
Dec 10, 2016·Frontiers in Microbiology·Bhaskar C M RamisettyRamachandran S Santhosh
Jul 15, 2016·Toxins·Meenakumari MuthuramalingamChristina R Bourne
Jul 26, 2017·Frontiers in Microbiology·Muriel C F van TeeselingFelipe Cava
Sep 14, 2019·Journal of Microbiological Methods·Fabián Lorenzo-DiazManuel Espinosa
Feb 15, 2021·Applied Microbiology and Biotechnology·Akriti SrivastavaLalit C Garg
Aug 31, 2021·RSC Chemical Biology·Rashi KahanAnna Barnard

❮ Previous
Next ❯

Methods Mentioned

BETA
ICEs
biosensors
aminoacylation
fluorescence
BRET
chemical modifications
antisense oligodeoxynucleotides
PCR

Software Mentioned

PezAT
BRET
GeneGuard
TAs

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.